Ignite Creation Date:
2024-05-05 @ 10:17 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00005073
Status:
TERMINATED
Last Update Posted:
2013-05-01
First Post:
2000-04-06
Brief Title:
Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-09
Start Date Type:
None
Primary Completion Date:
2003-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2003-03
Completion Date Type:
ACTUAL
First Submit Date:
2000-04-06
First Submit QC Date:
June 17 2004
Study First Post Date:
2004-06-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-04-30
Last Update Post Date:
2013-05-01
Last Update Post Date Type:
ESTIMATED